Visano Theranostics has been selected for JumpStart's Trailblazer HealthTech Accelerator, a prestigious 3-month program that provides healthcare startups with expert mentorship, regulatory guidance, and access to up to $275,000 in development services.

The Visano Solution

Enhancing The Future Of Ultrasound Imaging.

Visano Theranostics is transforming the landscape of medical imaging and therapy with our innovative nanobubble technology, designed to outperform traditional ultrasound contrast agents. Our nanobubbles last up to 20 times longer than microbubbles, providing extended imaging windows and enhanced diagnostic precision. Their nanoscale size allows for superior tissue penetration and the ability to target both vascular and extravascular biomarkers, unlocking applications beyond the reach of conventional agents. With a high yield production process and tunable properties, our platform supports a broad range of clinical uses, from foundational imaging to targeted diagnostics and ultrasound-mediated theranostics. This versatility positions Visano as a leader in advancing cost-effective, real-time ultrasound solutions that improve patient outcomes, reduce healthcare costs, and expand access to cutting-edge theranostics globally.
Nanobubbles Images

Meet Our Team

James P. Basilion, Ph.D.

James P. Basilion, Ph.D.

Inventor, Co-founder​

Professor of Radiology & BME, CWRU​ ​
30+ years of experience in molecular oncology, translational tech​

Agata A. Exner, Ph.D.

Agata A. Exner, Ph.D.

Inventor, Co-founder​

Director of the CWRU Center for Imaging Research and a leading expert in molecular imaging and theranostics.

Michael J. Haag, MS, MBA

Michael J. Haag, MS, MBA

Co-founder, Chief Executive Officer

Expert in tech transfer and startups with 25+ years experience, formerly at CWRU, now leading innovation through TherExel LLC.

About Our Technologies

Explore how nanobubble innovation is driving breakthroughs in cancer diagnosis and precision therapy.

Why Nanobubbles?

Revolutionizing cancer diagnosis and treatment with nanobubbles in the ever-evolving fight against cancer requires innovation. Traditional diagnostic tools just don’t cut it.

Lead Application.

Transforming the diagnosis and treatment of prostate cancer with nanobubble contrast agents. Prostate cancer is one of the most commonly diagnosed types of cancer.

Visano’s Solution: Targeted Nanobubble Therapy.

A new frontier in precision oncology, prostate cancer continues to be one of the most prevalent cancers in men worldwide.

Our Publications

Explore peer-reviewed studies and scientific breakthroughs highlighting the cutting-edge role of nanobubbles in diagnostics, cancer imaging, and more.

Latest News & Blogs

Discover recent breakthroughs, trends, and real-world applications of nanobubble technology across industries.

Visano’s Solution: Targeted Nanobubble Therapy

A New Frontier in Precision Oncology Prostate cancer continues to be one of the most prevalent cancers in men worldwide, […]

What We Solve and What We Do

Revolutionizing Prostate Cancer Diagnosis and Treatment with Nanobubble Contrast Agents Prostate cancer remains one of the most commonly diagnosed cancers […]

Why Nanobubbles?

VISANO: Revolutionizing Cancer Diagnosis and Treatment with Nanobubbles In the ever-evolving fight against cancer, innovation is crucial. Traditional diagnostic tools […]

Scroll to Top